Project Description
Palafox M,…, Gonzalez-Perez A,…, Sanchez-Guixé M,…, Lopez-Bigas N, …., Serra V
Nature Communications, DOI: 10.1038/s41467-022-32828-6
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancermariona2023-11-16T16:24:08+00:00
